📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Axys Pharmaceuticals

1.1 - Company Overview

Axys Pharmaceuticals Logo

Axys Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery, design, and development services for therapeutic small molecules addressing significant markets with major unmet medical needs; collaborates with large pharmaceutical companies to discover therapeutics for chronic diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Axys Pharmaceuticals

Genkyotex Logo

Genkyotex

HQ: Switzerland Website
  • Description: Provider of innovative drugs and platform technology that block NOX enzymes producing oxygen radicals to treat oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy. Offerings include setanaxib and a NOX inhibitor platform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genkyotex company profile →
Talecris Logo

Talecris

HQ: Spain Website
  • Description: Provider of plasma-derived protein therapies, produced and marketed by a biopharmaceutical company founded in 2004 and based in Barcelona, Spain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Talecris company profile →
Altor BioScience Logo

Altor BioScience

HQ: United States Website
  • Description: Provider of immunotherapeutic agents for cancer, viral infections, and autoimmune diseases, including ANKTIVA (N‑803), an IL‑15 receptor agonist for non‑muscle invasive bladder cancer; investigational cancer and viral therapies and vaccines (personalized neoepitope-based, HIV, HPV); Tri‑Ad5 vaccine for Lynch syndrome; STAR Fusion reagents for diagnosis/targeting, STAR Multimer reagents for research; and clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Altor BioScience company profile →
Acceleron Pharma Logo

Acceleron Pharma

HQ: United States Website
  • Description: Provider of novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases; engaged in developing, manufacturing, and commercializing these products, including the ACE-011 program, a novel bone-forming program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Acceleron Pharma company profile →
LEAF Pharmaceuticals Logo

LEAF Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology and healthcare products, including investigational anticancer drugs targeting solid tumors (LEAF-1401, LEAF-1701) with preclinical results showing reduced metastatic tumor burden in lung cancer models, superior performance in colorectal models, and minimal myelosuppression and gastrointestinal toxicity, plus LEAF-1404, a complex generic anticancer medicine manufactured under global cGMP.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LEAF Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Axys Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Axys Pharmaceuticals

2.2 - Growth funds investing in similar companies to Axys Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Axys Pharmaceuticals

4.2 - Public trading comparable groups for Axys Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Axys Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Axys Pharmaceuticals

What does Axys Pharmaceuticals do?

Axys Pharmaceuticals is a provider of discovery, design, and development services for therapeutic small molecules addressing significant markets with major unmet medical needs; collaborates with large pharmaceutical companies to discover therapeutics for chronic diseases.

Who are Axys Pharmaceuticals's competitors?

Axys Pharmaceuticals's competitors and similar companies include Genkyotex, Talecris, Altor BioScience, Acceleron Pharma, and LEAF Pharmaceuticals.

Where is Axys Pharmaceuticals headquartered?

Axys Pharmaceuticals is headquartered in United States.

How many employees does Axys Pharmaceuticals have?

Axys Pharmaceuticals has 1,000 employees 🔒.

When was Axys Pharmaceuticals founded?

Axys Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Axys Pharmaceuticals in?

Axys Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Axys Pharmaceuticals

Who are the top strategic acquirers in Axys Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Axys Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Axys Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Axys Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Axys Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Axys Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Axys Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Axys Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Axys Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Axys Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Axys Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Axys Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Axys Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Axys Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Axys Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Axys Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Axys Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Axys Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Axys Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Axys Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Axys Pharmaceuticals